Paragon 28, Inc. (NYSE:FNA – Get Free Report) major shareholder Mvm Partners, Llc sold 147,581 shares of the stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $10.28, for a total value of $1,517,132.68. Following the completion of the sale, the insider now owns 10,738,564 shares in the company, valued at approximately $110,392,437.92. The trade was a 1.36 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Paragon 28 Stock Performance
Shares of Paragon 28 stock opened at $10.04 on Monday. The company has a current ratio of 3.50, a quick ratio of 1.60 and a debt-to-equity ratio of 0.79. The stock’s fifty day moving average price is $6.71 and its 200-day moving average price is $7.21. The firm has a market cap of $840.55 million, a P/E ratio of -13.57 and a beta of 1.01. Paragon 28, Inc. has a 12 month low of $4.65 and a 12 month high of $14.79.
Paragon 28 (NYSE:FNA – Get Free Report) last posted its earnings results on Tuesday, November 12th. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.01. Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. The business had revenue of $62.30 million for the quarter, compared to the consensus estimate of $60.58 million. During the same quarter last year, the firm posted ($0.10) EPS. The company’s revenue for the quarter was up 18.0% on a year-over-year basis. On average, equities research analysts expect that Paragon 28, Inc. will post -0.66 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Paragon 28
Analyst Ratings Changes
A number of research firms have recently commented on FNA. Canaccord Genuity Group cut their price target on shares of Paragon 28 from $17.00 to $15.00 and set a “buy” rating on the stock in a report on Wednesday, November 13th. Needham & Company LLC boosted their price objective on shares of Paragon 28 from $11.00 to $13.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $12.00 target price (down from $15.00) on shares of Paragon 28 in a research report on Friday, August 9th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $15.60.
Check Out Our Latest Stock Report on FNA
About Paragon 28
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
Featured Articles
- Five stocks we like better than Paragon 28
- What Are the FAANG Stocks and Are They Good Investments?
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Top Biotech Stocks: Exploring Innovation Opportunities
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.